Filter by Year:

2016

2016,  
Neurology

Genetically decreased vitamin D and risk of Alzheimer disease.

Mokry, LE., et al.
2016,  
Annals of clinical and translational neurology

Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases.

Gagliano, SA., et al.
2016,  
European journal of human genetics : EJHG

SORL1 variants across Alzheimer's disease European American cohorts.

Fernández, MV., et al.
2016,  
Nature neuroscience

Novel genetic loci underlying human intracranial volume identified through genome-wide association.

Adams, HHH., et al.
2016,  
Translational psychiatry

Molecular genetic aetiology of general cognitive function is enriched in evolutionarily conserved regions.

Hill, WD., et al.
2016,  
Molecular and cellular probes

Genomics of Alzheimer's disease: Value of high-throughput genomic technologies to dissect its etiology.

Tosto, G.
2016,  
Neurology. Genetics

SORL1 mutations in early- and late-onset Alzheimer disease.

Cuccaro, ML., et al.
2016,  
Acta neuropathologica

Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging.

Nelson, PT., et al.
2016,  
Molecular psychiatry

Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.

Herold, C., et al.
2016,  
BMC systems biology

DGCA: A comprehensive R package for Differential Gene Correlation Analysis.

McKenzie, AT., et al.
2016,  
BMC neurology

Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.

Deming, Y., et al.
2016,  
Neurobiology of aging

ABCA7 p.G215S as potential protective factor for Alzheimer's disease.

Sassi, C., et al.
2016,  
JAMA neurology

The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease.

Tosto, G., et al.
2016,  
Molecular psychiatry

Assessing the genetic overlap between BMI and cognitive function.

Marioni, RE., et al.
2016,  
PLoS genetics

Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease.

Jakobsdottir, J., et al.
2016,  
Annals of clinical and translational neurology

Age-dependent effects of APOE ε4 in preclinical Alzheimer's disease.

Bonham, LW., et al.
2016,  
Nature genetics

NEK1 variants confer susceptibility to amyotrophic lateral sclerosis.

Kenna, KP., et al.
2016,  
Neurology

Incident parkinsonism in older adults without Parkinson disease.

Buchman, AS., et al.
2016,  
Molecular neurobiology

PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses.

Zhang, D., et al.
2016,  
Journal of neurology, neurosurgery, and psychiatry

Traumatic brain injury history is associated with earlier age of onset of frontotemporal dementia.

LoBue, C., et al.
2016,  
Biological psychiatry

Genetic Markers of Human Evolution Are Enriched in Schizophrenia.

Srinivasan, S., et al.
2016,  
Acta neuropathologica

Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci.

Allen, M., et al.
2016,  
Bioinformatics (Oxford, England)

Pathway analysis by randomization incorporating structure-PARIS: an update.

Butkiewicz, M., et al.
2016,  
Nature genetics

Detection and interpretation of shared genetic influences on 42 human traits.

Pickrell, JK., et al.
2016,  
European journal of human genetics : EJHG

Evaluation of power of the Illumina HumanOmni5M-4v1 BeadChip to detect risk variants for human complex diseases.

Xing, C., et al.
2016,  
The New England journal of medicine

Incidence of Dementia over Three Decades in the Framingham Heart Study.

Satizabal, C., et al.
2016,  
Journal of Alzheimer's disease : JAD

Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study.

Camargo, EC., et al.
2016,  
BMC genomics

Variants in CCL16 are associated with blood plasma and cerebrospinal fluid CCL16 protein levels.

Ebbert, MTW., et al.
2016,  
Journal of Alzheimer's disease : JAD

Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.

Chouraki, V., et al.
2016,  
The Lancet. Neurology

Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies.

2016,  
BMC genomics

Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels.

Staley, LA., et al.
2016,  
BMC genomics

Genome-wide association study of prolactin levels in blood plasma and cerebrospinal fluid.

Staley, LA., et al.
2016,  
Neurology. Genetics

ABCA7 frameshift deletion associated with Alzheimer disease in African Americans.

Cukier, HN., et al.
2016,  
JAMA neurology

Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.

Risacher, SL., et al.
2016,  
JAMA neurology

Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer Disease.

Yokoyama, JS., et al.
2016,  
Alzheimer's & dementia : the journal of the Alzheimer's Association

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.

Allen, GI., et al.
2016,  
Science translational medicine

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.

Scott, RA., et al.
2016,  
BMC bioinformatics

A comprehensive database of high-throughput sequencing-based RNA secondary structure probing data (Structure Surfer).

Berkowitz, ND., et al.
2016,  
Neurobiology of aging

Assessment of the genetic variance of late-onset Alzheimer's disease.

Ridge, PG., et al.
2016,  
Neurobiology of aging

The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable.

Mez, J., et al.
2016,  
Genome medicine

Identification of the BRD1 interaction network and its impact on mental disorder risk.

Fryland, T., et al.
2016,  
Stroke

Association of Ideal Cardiovascular Health With Vascular Brain Injury and Incident Dementia.

Pase, MP., et al.
2016,  
Neurobiology of aging

The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume.

Lupton, MK., et al.
2016,  
Alzheimer's & dementia : the journal of the Alzheimer's Association

Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk.

Hohman, TJ., et al.
2016,  
Neurology

Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies.

White, LR., et al.
2016,  
Annals of translational medicine

Toward precision medicine in Alzheimer's disease.

Reitz, C.
2016,  
European journal of neurology

Interleukin-6, interleukin-6 receptor gene variant, small-vessel disease and incident dementia.

Miwa, K., et al.
2016,  
Neurology

Low-frequency and common genetic variation in ischemic stroke: The METASTROKE collaboration.

Malik, R., et al.
2016,  
PLoS genetics

Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.

Choi, SH., et al.
2016,  
The New England journal of medicine

Incidence of Dementia over Three Decades in the Framingham Heart Study.

Satizabal, CL., et al.
2016,  
Neurology. Genetics

Segregation of a rare TTC3 variant in an extended family with late-onset Alzheimer disease.

Kohli, MA., et al.
2016,  
Stroke

Genome-Wide Association Analysis of Young-Onset Stroke Identifies a Locus on Chromosome 10q25 Near HABP2.

Cheng, Y., et al.
2016,  
BMC genetics

Family-based approaches: design, imputation, analysis, and beyond.

Wijsman, EM.
2016,  
Neurobiology of aging

Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium.

Hohman, TJ., et al.
2016,  
Alzheimer's & dementia : the journal of the Alzheimer's Association

Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.

Ebbert, MTW., et al.
2016,  
Molecular psychiatry

GWAS for executive function and processing speed suggests involvement of the CADM2 gene.

Ibrahim-Verbaas, CA., et al.
2016,  
Alzheimer's & dementia (Amsterdam, Netherlands)

Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke.

Weinstein, G., et al.
2016,  
BMC proceedings

Estimating relationships between phenotypes and subjects drawn from admixed families.

Blue, EM., et al.
2016,  
BMC proceedings

Identity-by-descent estimation with population- and pedigree-based imputation in admixed family data.

Saad, M., et al.
2016,  
PloS one

Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer's Disease.

Sassi, C., et al.
2016,  
PloS one

Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.

Karch, CM., et al.
2016,  
Journal of Alzheimer's disease : JAD

Self-Reported Traumatic Brain Injury and Mild Cognitive Impairment: Increased Risk and Earlier Age of Diagnosis.

LoBue, C., et al.
2016,  
Alzheimer disease and associated disorders

Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study.

Walter, S., et al.
2016,  
Current protocols in human genetics

In Silico Functional Annotation of Genomic Variation.

Butkiewicz, M.
2016,  
Alzheimer's & dementia : the journal of the Alzheimer's Association

Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.

Kunkle, BW., et al.
2016,  
Molecular psychiatry

A novel Alzheimer disease locus located near the gene encoding tau protein.

Jun, G., et al.
2016,  
Scientific reports

Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits.

Deming, Y., et al.
2016,  
Nucleic acids research

DASHR: database of small human noncoding RNAs.

Leung, YY., et al.
2016,  
Neurobiology of aging

A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin.

Deming, Y., et al.